Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray. Virpax Pharmaceuticals Inc is a preclinical stage biopharmaceutical company. The company is focused on developing pharmaceutical product candidates for pain management. Its product portfolio includes Topical metered-dose spray; Liposomal in Hydrogel encapsulation; and Enkephalin Intranasal spray.
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central...
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a company specializing in developing pharmaceutical products for pain management, announced that it has been granted an...
New York, NY, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Spartan Capital Securities, LLC, a leading investment banking firm, is pleased to announce its role as the sole placement agent in Virpax...
Virpax Pharmaceuticals, Inc. (Nasdaq: VRPX) (“Virpax” or the “Company”), a preclinical-stage pharmaceutical company focused in novel and proprietary drug delivery systems across various pain...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.150101 | -23.0888738827 | 0.650101 | 0.72 | 0.491 | 2729485 | 0.59223189 | CS |
| 4 | -0.1071 | -17.6412452644 | 0.6071 | 0.79 | 0.491 | 754692 | 0.60121339 | CS |
| 12 | -0.31 | -38.2716049383 | 0.81 | 0.85 | 0.3625 | 404266 | 0.59153073 | CS |
| 26 | -0.2178 | -30.3427138479 | 0.7178 | 3.39 | 0.3625 | 3157274 | 1.34656493 | CS |
| 52 | -5.701 | -91.9367843896 | 6.201 | 6.201 | 0.3625 | 1703674 | 1.45990253 | CS |
| 156 | -40.1 | -98.7684729064 | 40.6 | 56.2 | 0.3625 | 677147 | 6.39528745 | CS |
| 260 | -79.5 | -99.375 | 80 | 359.799 | 0.3625 | 1006844 | 59.48199753 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
